SMR · NuScale Power Corporation

The thesis

NuScale Power's remaining case is a binding power purchase agreement between its partner ENTRA1 Energy and the Tennessee Valley Authority (TVA) by 31 December 2026. The shares closed at $5.38 on 22 October 2026 (adjusted daily close), with no customer commitment behind that price. The third-quarter report on 5 November 2026 is the next test of whether the talks have advanced.

The selling has accelerated since the last update. Barclays cut NuScale to Underweight with a $5 target on 20 October 2026, Citigroup lowered its Sell target to $4 on 21 October 2026, and Truist kept Hold with an $8 target on 22 October 2026, all per Benzinga. Benzinga reported on 20 October 2026 that the shares hit a new low. The shares now trade below the $6.50 close level that the previous note set as its break point.

The narrative is saturated: the story is well known, analysts are lowering targets rather than initiating coverage, and the shares are 88.0% below the 52-week high of $44.87. The 3 September 2025 ENTRA1–TVA announcement described up to 6 gigawatts of deployment. It stays non-binding until a power purchase agreement is signed, and NuScale said on 5 August 2026 that talks were continuing.

Bullish and bearish views on NuScale Power Corporation

The bull case on NuScale Power Corporation (SMR), in brief: A signed agreement would reset the story. The bear case: Revenue has yet to confirm deployment.

Bull case

• A signed agreement would reset the story. The 3 September 2025 ENTRA1–TVA announcement described up to six small modular reactors and up to 6 gigawatts, with power sold to TVA under future agreements. Management has pointed to a power purchase agreement by the end of 2026, per October 2026 coverage.
• Reported liquidity covers a long negotiation. NuScale reported $1.9 billion in cash, cash equivalents and short- and long-term investments at 30 June 2026, per its Q2 2026 results filed with the SEC. That is a June balance and predates later spending or share issuance.
• Some analysts still carry high targets. B. Riley (Buy) set a $15 target on 14 August 2026 and Canaccord Genuity (Buy) set $15 on 6 August 2026. Truist's $8 target on 22 October 2026 is $2.62 above the last close.
• Shares are deeply oversold. The 14-day relative strength index (RSI), a momentum gauge where readings under 30 mark heavy selling, stood at 17.9 on 22 October 2026. The shares fell 37.0% over the three months to that date.

Bear case

• Revenue has yet to confirm deployment. NuScale reported $75,000 of revenue for the quarter ended 30 June 2026, against an analyst estimate of $8.91 million cited by Benzinga on 5 August 2026.
• Sell-side targets now sit below the price. Citigroup's target is $4 (Sell, 21 October 2026), Barclays' is $5 (Underweight, 20 October 2026) and UBS's is $6 (Sell, 11 September 2026). Three of the four most recent target changes are lower than the last close.
• Share supply is authorized. NuScale disclosed on 11 August 2026 an at-the-market program of up to $750 million of Class A stock. The third-quarter filing would show how much was sold.
• Later settlement figures are not yet published.
• The timeline rests on one counterparty. The agreement needs TVA to commit, and NuScale does not control that decision.

Price setup

The shares closed at $5.38 on 22 October 2026, 88.0% below the 52-week high of $44.87. No moving average sits near the price; every widely watched average is far above it after the decline. The three-month change is a fall of 37.0%, and the 14-day RSI of 17.9 shows the selling has been one-directional.

Crowding evidence points to a heavily negative crowd rather than a stretched rally: elevated short interest as of 15 September 2026, an authorized $750 million at-the-market program that can add supply into any rebound, and an earnings date 14 days away. No insider-transaction data is in hand for this update.

Catalysts, next 30 days

• 5 November 2026: third-quarter 2026 results and call at 5:00 p.m. ET (NuScale press release). First update on ENTRA1–TVA talks, cash and any shares sold under the at-the-market program.
• 31 December 2026 (beyond 30 days): management's horizon for a definitive power purchase agreement. The case turns on it.

Elapsed catalysts

• ~26 October 2026 (est.): short interest for the 15 October 2026 settlement. Shows whether bearish positioning grew during the slide below $8. (passed 1d ago)

What would change the view

The case breaks if the shares close below $4.50, below every analyst target in the past month except Citigroup's $4. It also breaks if 31 December 2026 passes without a definitive ENTRA1–TVA power purchase agreement, or if the 5 November 2026 report shows TVA talks stalled.

A signed, binding agreement with stated volumes and pricing would move the case toward the bull side. Third-quarter revenue near the analyst estimate, with limited at-the-market sales, would also soften the bear case. The rating is unchanged since 10 October 2026 because the new analyst cuts add price pressure but no new company fact.

What it trades with

NuScale trades with the listed nuclear group. Benzinga reported on 6 October 2026 that Google signed a 20-year arrangement tied to Constellation Energy's reactors and that nuclear stocks rallied, yet NuScale fell more than 20% in the following two weeks on its own analyst cuts, so company-specific news is dominating. Benzinga's 13 October 2026 piece on speculative uranium buying does not show up in NuScale's price. The sample of recent sessions is too small to draw a stable correlation.